The ordinary people: the controlling shareholder pledged 1.63% of the shares for extension.

The notice from the general public: The controlling shareholder of the company, the Lao Bai Xing Pharmaceutical Group, has extended the repurchase of 12.35 million shares pledged to China Bank Securities. The pledge start date was June 5, 2025, with the original maturity date being June 4, 2026, and now extended to June 3, 2027. The shares involved account for 6.84% of its holdings and 1.63% of the total shares of the company. The pharmaceutical group holds 180 million shares, representing 23.78% of the total shares, with a total of 126 million shares pledged, accounting for 69.85% and 16.61%. The controlling shareholder and persons acting in concert jointly hold 194 million shares, accounting for 25.57%, with a total of 126 million shares pledged, representing 64.96% and 16.61%. The pharmaceutical group has 38.15 million shares pledged to mature in the next year, representing 21.14% of its holdings and 5.03% of the total shares, with a corresponding financing balance of 267 million yuan.